Emerging therapies for the treatment of patients with advanced neuroendocrine tumors

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.12, Iss.2, 2007-05, pp. : 253-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors

By Dasanu Constantin A Majumder Shounak Gopal Srila Stoica-Mustafa Elena Trikudanathan Guru

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 461-471

Informa Healthcare

Access to resources Recommend Favorite

Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 28-39

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2013-12 ,pp. : 28-39

Bentham Science Publishers

Access to resources Recommend Favorite

Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies

By Nandy Nina

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1649-1658

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

By Bisht Savita Feldmann Georg Brossart Peter

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite